Teva Pharmaceuticals
TEVA
TEVA
436 hedge funds and large institutions have $5.76B invested in Teva Pharmaceuticals in 2019 Q4 according to their latest regulatory filings, with 77 funds opening new positions, 127 increasing their positions, 135 reducing their positions, and 58 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
0.32% less ownership
Funds ownership: 54.15% → 53.83% (-0.32%)
6% less repeat investments, than reductions
Existing positions increased: 127 | Existing positions reduced: 135
40% less call options, than puts
Call options by funds: $354M | Put options by funds: $586M
Holders
436
Holding in Top 10
5
Calls
$354M
Puts
$586M
Top Buyers
| 1 | +$82.4M | |
| 2 | +$80.9M | |
| 3 | +$52.4M | |
| 4 |
Two Sigma Investments
New York
|
+$23.4M |
| 5 |
JP Morgan Chase
New York
|
+$20.7M |
Top Sellers
| 1 | -$261M | |
| 2 | -$211M | |
| 3 | -$46.1M | |
| 4 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$39.6M |
| 5 |
Jane Street
New York
|
-$28.7M |